NIH Research Festival 2012 Program - Research Festival - National ...

Concurrent Symposia Session IV
Natcher Conference Center
Balcony A
Patent & Technology Transfer Interest Group;
Biomedical Business Interest Group
Commercial development of my own research
discoveries: The personal stories of former
NIH scientists
Co-Chairs: Steven Ferguson, OD; and Todd Chappell, OD
Long before NCATS, CTSAs and similar programs supporting translational science came
to NIH, intramural investigators often fulfilled their vision of achieving the translational
product goals for their research by leaving NIH to start or co-found their own companies.
By practicing translational science of the “DIY (do-it-yourself) variety” these investigators
were able to achieve major personal, scientific and professional goals -- and have both
important clinical and economic impacts for their science. In Maryland alone over 50 of the
founders of Maryland bioscience/biomedical companies spent some time as intramural
investigators. Without this talent from the NIH intramural program, Maryland would not
have one of the top concentrations of bioscience/biomedical companies in the country.
This mini-symposium will feature presentations from a variety of distinguished former
NIH intramural scientists who became company founders and will share the story of their
science and passion for bringing it forward for development.
Todd Chappell, OD
NIH Entrepreneur-in-Residence: Helping scientists determine if their bench discoveries
truly do have commercial applications
Frank Robey, Ariavax
Vaccine immunogens that are small molecules that are covalently conjugated to
nanoparticles
Martha Knight, CC Biotech
Using novel counter-current chromatography approaches to purify bio-active
synthetic peptides
Sheri Bale, GeneDX
Making clinical testing available to people with rare genetic conditions and their families
Lawrence Tamarkin, Cytimmune
Colloidal gold-based drug compounds which harness the therapeutic potential of
potent anti-cancer agents
72
Thursday, October 11, 2012
Noon–2:00 p.m.